Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.2%

19 terminated/withdrawn out of 363 trials

Success Rate

89.3%

+2.8% vs industry average

Late-Stage Pipeline

13%

48 trials in Phase 3/4

Results Transparency

4%

6 of 159 completed trials have results

Key Signals

46 recruiting6 with results15 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
158(57.0%)
Phase 2
53(19.1%)
Phase 4
34(12.3%)
Phase 1
16(5.8%)
Phase 3
14(5.1%)
Early Phase 1
2(0.7%)
277Total
N/A(158)
Phase 2(53)
Phase 4(34)
Phase 1(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (363)

Showing 20 of 363 trials
NCT07540026Not ApplicableRecruiting

Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled Trial

Role: lead

NCT07537283Not ApplicableCompleted

Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy

Role: lead

NCT07139379Not ApplicableRecruiting

Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy

Role: lead

NCT06687460Not ApplicableEnrolling By Invitation

Distal Nerve Electrical Stimulation for Neuromuscular Reinnervation

Role: lead

NCT02481336Active Not Recruiting

To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity

Role: lead

NCT07525713Not ApplicableNot Yet Recruiting

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Role: lead

NCT05927857Phase 1Recruiting

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Role: collaborator

NCT05048901Phase 1Recruiting

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Role: collaborator

NCT04180072Not ApplicableActive Not Recruiting

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Role: collaborator

NCT06127446Recruiting

The Registry of Genetic Alterations of Taiwan Ovarian Cancer

Role: collaborator

NCT06854926Not ApplicableCompleted

Helping Relationship From Significant Others in Patients With Hypertension

Role: lead

NCT06162650Phase 2Recruiting

Total Neoadjuvant Therapy in Rectal Cancer

Role: lead

NCT07500662Not ApplicableCompleted

The Effect of Ankle Foot Orthosis Influences the Prefrontal Load in Stroke Patients During Dual Task Walking

Role: lead

NCT07486375Not ApplicableCompleted

Self-Management App for Blood Pressure and Well-Being in Postpartum Women With Hypertensive Disorders of Pregnancy

Role: lead

NCT06073990Not ApplicableActive Not Recruiting

Brief Behavioral Therapy for Insomnia(BBTi) in Middle-aged and Older Adults With Chronic Insomnia

Role: lead

NCT07394231Not ApplicableCompleted

Exploring Innovative Strategies to Enhance Eye-Hand Coordination and Cognitive Functions Through Drone Catching Exercise.

Role: lead

NCT07387458Completed

Bone Turnover Markers and Vitamin D Survey Among Health Professionals in Taiwan

Role: lead

NCT03344718Completed

Metabolic Syndrome and Vitamin D Level in Old People

Role: lead

NCT06380920Not ApplicableActive Not Recruiting

Function Definition and Clinical Validation of Digital Health App: Using Weight Management as An Example

Role: lead

NCT07369791Phase 2Not Yet Recruiting

Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.

Role: collaborator